Claranova Valuation

Is CLA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CLA (€1.31) is trading below our estimate of fair value (€5.09)

Significantly Below Fair Value: CLA is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLA?

Key metric: As CLA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CLA. This is calculated by dividing CLA's market cap by their current revenue.
What is CLA's PS Ratio?
PS Ratio0.1x
Sales€495.70m
Market Cap€74.23m

Price to Sales Ratio vs Peers

How does CLA's PS Ratio compare to its peers?

The above table shows the PS ratio for CLA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average6x
ALSTW Streamwide
3.6x12.2%€74.2m
ALCBI Crypto Blockchain Industries
16.7xn/a€68.2m
COH Coheris
3.1xn/a€44.7m
ALITL IT Link
0.6x5.8%€45.2m
CLA Claranova
0.1x5.0%€74.2m

Price-To-Sales vs Peers: CLA is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (6x).


Price to Sales Ratio vs Industry

How does CLA's PS Ratio compare vs other companies in the FR Software Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.2.0x8.3%
CLA Claranova
0.1x5.0%US$78.15m
ALPRG Prologue
0.2x3.4%US$19.86m
EOS Acteos
0.3xn/aUS$4.40m
No more companies available in this PS range
CLA 0.1xIndustry Avg. 2.0xNo. of Companies5PS01.63.24.86.48+
3 CompaniesEstimated GrowthMarket Cap
Industry Avg.2.0x14.7%
CLA Claranova
0.1x60.0%US$78.15m
No more companies

Price-To-Sales vs Industry: CLA is good value based on its Price-To-Sales Ratio (0.1x) compared to the French Software industry average (2x).


Price to Sales Ratio vs Fair Ratio

What is CLA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.1x
Fair PS Ratio0.5x

Price-To-Sales vs Fair Ratio: CLA is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.5x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CLA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.31
€3.90
+197.7%
53.8%€6.00€1.80n/a2
Nov ’25€1.41
€4.50
+218.7%
55.6%€7.00€2.00n/a2
Oct ’25€1.51
€4.65
+207.5%
50.5%€7.00€2.30n/a2
Sep ’25€1.46
€4.65
+218.5%
50.5%€7.00€2.30n/a2
Aug ’25€1.73
€4.75
+174.9%
47.4%€7.00€2.50n/a2
Jul ’25€1.77
€4.75
+167.8%
47.4%€7.00€2.50n/a2
Jun ’25€2.18
€4.75
+118.4%
47.4%€7.00€2.50n/a2
May ’25€2.43
€4.75
+95.5%
47.4%€7.00€2.50n/a2
Apr ’25€2.59
€4.75
+83.4%
47.4%€7.00€2.50n/a2
Mar ’25€2.46
€4.31
+75.1%
33.2%€6.00€2.50n/a3
Feb ’25€2.15
€4.14
+93.0%
39.7%€6.00€2.00n/a3
Jan ’25€2.13
€4.14
+94.8%
39.7%€6.00€2.00n/a3
Dec ’24€1.52
€4.14
+173.1%
39.7%€6.00€2.00n/a3
Nov ’24€1.34
€4.24
+216.4%
35.8%€6.00€2.30€1.413
Oct ’24€1.46
€4.24
+190.8%
35.8%€6.00€2.30€1.513
Sep ’24€1.75
€4.24
+142.0%
35.8%€6.00€2.30€1.463
Aug ’24€1.51
€4.57
+203.3%
42.0%€7.00€2.30€1.733
Jul ’24€1.69
€5.71
+238.3%
22.6%€7.00€4.42€1.772
Jun ’24€1.84
€5.06
+175.3%
32.3%€7.00€3.00€2.183
May ’24€2.01
€5.39
+168.7%
26.8%€7.00€3.50€2.433
Apr ’24€2.09
€5.39
+157.7%
26.8%€7.00€3.50€2.593
Mar ’24€2.02
€5.39
+166.7%
26.8%€7.00€3.50€2.463
Feb ’24€2.59
€5.37
+107.0%
23.1%€7.00€4.00€2.153
Jan ’24€2.75
€5.37
+95.3%
23.1%€7.00€4.00€2.133
Dec ’23€2.78
€5.37
+93.0%
23.1%€7.00€4.00€1.523
Nov ’23€2.35
€5.37
+128.4%
23.1%€7.00€4.00€1.343

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.


Discover undervalued companies